Stocks

The table gives an overview of all stocks, alphabetically sorted.
 K-Fast Holding B KFASTB 0.00 0.00   
 K2A Knaust & Andersson Fastigh K2APREF Jan 24, 2020 354.00 +0.57   
 K2A Knaust & Andersson Fastigh K2AB Jan 24, 2020 169.00 +0.60   
 KABE Group B KABEB Jan 24, 2020 150.50 -3.22   
 Kakel Max KAKEL Jan 24, 2020 11.90 0.00   
 Kallebäck Property Invest KAPIAB Jan 24, 2020 192.50 -1.03   
 Kambi Group KAMBI Jan 24, 2020 129.50 -0.15   
 Kancera KAN Jan 24, 2020 0.60 +3.10   
 Karessa Pharma Holding KARE Jan 24, 2020 2.76 +0.73   
 Karnov Group KAR Jan 24, 2020 52.50 +1.94   
 Karo Pharma KARO Jan 24, 2020 43.64 +0.32   
 Karolinska Development B KDEV Jan 24, 2020 3.47 +0.87   
 Kentima Holding B KENH Jan 24, 2020 1.25 -5.28   
 Kid KIDO Jan 24, 2020 61.00 0.00   
 Kindred Group SDB KINDSDB Jan 24, 2020 48.75 -0.79   
 Kinnevik A KINVA Jan 24, 2020 237.00 +0.85   
 Kinnevik B KINVB Jan 24, 2020 234.60 +1.51   
 Kitron KITO Jan 24, 2020 10.34 0.00   
 Klaria Pharma Holding KLAR Jan 24, 2020 4.94 -0.60   
 Klövern A KLOVA Jan 24, 2020 23.90 +1.70   
 Klövern B KLOVB Jan 24, 2020 23.84 +1.45   
 Klövern Pref KLOVPREF Jan 24, 2020 378.00 -0.40   
 Knowit KNOW Jan 24, 2020 203.50 -0.25   
 Kollect on Demand Holding KOLL Jan 24, 2020 8.10 0.00   
 Komplett Bank KOMPO Jan 24, 2020 12.42 0.00   
 Kongsberg Automotive ASA KOAO Jan 24, 2020 5.05 0.00   
 Kongsberg Gruppen KOGO Jan 24, 2020 144.70 0.00   
 Kontigo Care KONT Jan 24, 2020 4.58 +2.92   
 Kopparbergs B KOBRB Jan 24, 2020 171.60 +3.00   
 Kopy Goldfields KOPY Jan 24, 2020 1.12 +7.21   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK